Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory Syndrome

Our results add strength to the hypothesis that the combination of ribavirin and corticosteroids has no therapeutic benefit when given early during severe acute respiratory syndrome infection. Further studies may investigate the effects of these treatments later in disease course.